Abstract
Ductal carcinoma in situ (DCIS) can be visualized by multiple imaging modalities including mammography, digital breast tomosynthesis (DBT), ultrasound, and breast magnetic resonance imaging (MRI). It can manifest as a mass or architectural distortion; however, it most commonly presents as suspicious calcifications. Fine linear or fine linear branching calcifications in a segmental distribution have the highest risk of malignancy. Most mammographic calcifications are benign; however, those which are malignant are usually associated with DCIS. The transition from film screen to digital mammography has resulted in an increase in the diagnosis of DCIS because of digital mammography’s higher detection rate for calcifications.
The addition of DBT to digital mammography does not appear to increase the detection of DCIS. The detection of calcifications has been shown to be slightly better with digital mammography than with DBT. The morphology of calcifications is not as well visualized with DBT.
The ultrasound (US) findings of DCIS are nonspecific and often subtle. The most common US finding of DCIS is a mass. Although US is less sensitive than mammography for detecting calcifications, malignant calcifications are more often visualized than those located in benign tissue.
MRI is the most sensitive method for detecting DCIS; however, its main disadvantage is the high false-positive rate. The most common appearance of DCIS on MRI is nonmass enhancement with a clumped internal enhancement pattern. The kinetic curve for DCIS is usually typical for malignancy with a rapid initial enhancement with a delayed plateau phase being most common. DCIS can also have a benign-appearing curve; therefore, imaging interpretation should be based mainly on the morphology of the lesion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yang WT, Tse GM. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. AJR Am J Roentgenol. 2004;182:101–10.
Wright B, Shumak R. Part II. Medical imaging of ductal carcinoma in situ. Curr Probl Cancer. 2000;24:112–24.
Yamada T, Mori N, Watanabe M, Kimijima I, Okumoto T, Seiji K, et al. Radiologic-pathologic correlation of ductal carcinoma in situ. Radiographics. 2010;30:1183–98.
Farshid G, Downey P, Gill PG. Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical intervention. Breast. 2007;16:161–71.
Koutalonis M, Delis H, Pascoal A, Spyrou G, Costaridou L, Panayiotakis G. Can electronic zoom replace magnification in mammography? A comparative Monte Carlo study. Br J Radiol. 2010;83:569–77.
Kim MJ, Kim EK, Kwak JY, Son EJ, Youk JH, Choi SH, et al. Characterization of microcalcification: can digital monitor zooming replace magnification mammography in full-field digital mammography? Eur Radiol. 2009;19:310–7.
Leung JW, Sickles EA. The probably benign assessment. Radiol Clin North Am. 2007;45:773–89.
American College of Radiology (ACR). ACR BI-RADS® Mammography. In: Sickles EA, D’Orsi CJ, Bassett LW, Appleton CM, Berg WA, Burnside ES et al, editors. ACR BI-RADS® Atlas, breast imaging reporting and data system. 5th ed. Reston: American College of Radiology; 2013.
Liberman L, Abramson AF, Squires FB, Glassman JR, Morris EA, Dershaw DD. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories. AJR Am J Roentgenol. 1998;171:35–40.
Berg WA, Arnoldus CL, Teferra E, Bhargavan M. Biopsy of amorphous breast calcifications: pathologic outcome and yield at stereotactic biopsy. Radiology. 2001;221:495–503.
Burnside ES, Ochsner JE, Fowler KJ, Fine JP, Salkowski LR, Rubin DL, et al. Use of microcalcification descriptors in BI-RADS 4th edition to stratify risk of malignancy. Radiology. 2007;242:388–95.
Bent CK, Bassett LW, D’Orsi CJ, Sayre JW. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories. AJR Am J Roentgenol. 2010;194:1378–83.
Stomper PC, Geradts J, Edge SB, Levine EG. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am J Roentgenol. 2003;181:1679–84.
Evans A, Pinder S, Wilson R, Sibbering M, Poller D, Elston C, et al. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR Am J Roentgenol. 1994;162:1307–11.
Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med. 2005;353:1773–83.
Obenauer S, Luftner-Nagel S, von Heyden D, Munzel U, Baum F, Grabbe E. Screen film vs full-field digital mammography: image quality, detectability and characterization of lesions. Eur Radiol. 2002;12:1697–702.
Berns EA, Hendrick RE, Cutter GR. Performance comparison of full-field digital mammography to screen-film mammography in clinical practice. Med Phys. 2002;29:830–4.
Vigeland E, Klaasen H, Klingen TA, Hofvind S, Skaane P. Full-field digital mammography compared to screen film mammography in the prevalent round of a population-based screening programme: the vestfold county study. Eur Radiol. 2008;18:183–91.
Del Turco MR, Mantellini P, Ciatto S, Bonardi R, Martinelli F, Lazzari B, et al. Full-field digital versus screen-film mammography: comparative accuracy in concurrent screening cohorts. AJR Am J Roentgenol. 2007;189:860–6.
Weigel S, Decker T, Korsching E, Hungermann D, Bocker W, Heindel W. Calcifications in digital mammographic screening: improvement of early detection of invasive breast cancers? Radiology. 2010;255:738–45.
Bluekens AM, Holland R, Karssemeijer N, Broeders MJ, den Heeten GJ. Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study. Radiology. 2012;265:707–14.
Weigel S, Heindel W, Heidinger O, Berkemeyer S, Hense HW. Digital mammography screening: association between detection rate and nuclear grade of ductal carcinoma in situ. Radiology. 2014;271:38–44.
Burke ET, Braeuning MP, McLelland R, Pisano ED, Cooper LL. Paget disease of the breast: a pictorial essay. Radiographics. 1998;18:1459–64.
Niklason LT, Christian BT, Niklason LE, Kopans DB, Castleberry DE, Opsahl-Ong BH, et al. Digital tomosynthesis in breast imaging. Radiology. 1997;205:399–406.
Rafferty EA, Park JM, Philpotts LE, Poplack SP, Sumkin JH, Halpern EF, et al. Diagnostic accuracy and recall rates for digital mammography and digital mammography combined with one-view and two-view tomosynthesis: results of an enriched reader study. AJR Am J Roentgenol. 2014;202:273–81.
Skaane P, Bandos AI, Gullien R, Eben EB, Ekseth U, Haakenaasen U, et al. Comparison of digital mammography alone and digital mammography plus tomosynthesis in a population-based screening program. Radiology. 2013;267:47–56.
Spangler ML, Zuley ML, Sumkin JH, Abrams G, Ganott MA, Hakim C, et al. Detection and classification of calcifications on digital breast tomosynthesis and 2D digital mammography: a comparison. AJR Am J Roentgenol. 2011;196:320–4.
Rafferty EA, Park JM, Philpotts LE, Poplack SP, Sumkin JH, Halpern EF, et al. Assessing radiologist performance using combined digital mammography and breast tomosynthesis compared with digital mammography alone: results of a multicenter, multireader trial. Radiology. 2013;266:104–13.
Gur D, Abrams GS, Chough DM, Ganott MA, Hakim CM, Perrin RL, et al. Digital breast tomosynthesis: observer performance study. AJR Am J Roentgenol. 2009;193:586–91.
Haas BM, Kalra V, Geisel J, Raghu M, Durand M, Philpotts LE. Comparison of tomosynthesis plus digital mammography and digital mammography alone for breast cancer screening. Radiology. 2013;269:694–700.
Andersson I, Ikeda DM, Zackrisson S, Ruschin M, Svahn T, Timberg P, et al. Breast tomosynthesis and digital mammography: a comparison of breast cancer visibility and BIRADS classification in a population of cancers with subtle mammographic findings. Eur Radiol. 2008;18:2817–25.
Berg WA, Blume JD, Cormack JB, Mendelson EB, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151–63.
Wang LC, Sullivan M, Du H, Feldman MI, Mendelson EB. US appearance of ductal carcinoma in situ. Radiographics. 2013;33:213–28.
Park JS, Park YM, Kim EK, Kim SJ, Han SS, Lee SJ, et al. Sonographic findings of high-grade and non-high-grade ductal carcinoma in situ of the breast. J Ultrasound Med. 2010;29:1687–97.
Soo MS, Baker JA, Rosen EL. Sonographic detection and sonographically guided biopsy of breast microcalcifications. AJR Am J Roentgenol. 2003;180:941–8.
Bazzocchi M, Zuiani C, Panizza P, Del Frate C, Soldano F, Isola M, et al. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. AJR Am J Roentgenol. 2006;186:1723–32.
Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010:150–1.
Kuhl CK, Schrading S, Bieling HB, Wardelmann E, Leutner CC, Koenig R, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370:485–92.
Schouten vanderVAP, Boetes C, Bult P, Wobbes T. The value of magnetic resonance imaging in diagnosis and size assessment of in situ and small invasive breast carcinoma. Am J Surg. 2006;192:172–8.
Santamaria G, Velasco M, Farrus B, Zanon G, Fernandez PL. Preoperative MRI of pure intraductal breast carcinoma-a valuable adjunct to mammography in assessing cancer extent. Breast. 2008;17:186–94.
Turnbull L, Brown S, Harvey I, Olivier C, Drew P, Napp V, et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet. 2010;375:563–71.
Greenwood HI, Heller SL, Kim S, Sigmund EE, Shaylor SD, Moy L. Ductal carcinoma in situ of the breasts: review of MR imaging features. Radiographics. 2013;33:1569–88.
Jansen SA, Newstead GM, Abe H, Shimauchi A, Schmidt RA, Karczmar GS. Pure ductal carcinoma in situ: kinetic and morphologic MR characteristics compared with mammographic appearance and nuclear grade. Radiology. 2007;245:684–91.
Rosen EL, Smith-Foley SA, DeMartini WB, Eby PR, Peacock S, Lehman CD. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Breast J. 2007;13:545–50.
Chan S, Chen JH, Agrawal G, Lin M, Mehta RS, Carpenter PM, et al. Characterization of pure ductal carcinoma in situ on dynamic contrast-enhanced MR imaging: do nonhigh grade and high grade show different imaging features? J Oncol. 2010 (Epub ahead of print). doi:10.1155/2010/431341.
Tozaki M, Igarashi T, Fukuda K. Breast MRI using the VIBE sequence: clustered ring enhancement in the differential diagnosis of lesions showing non-masslike enhancement. AJR Am J Roentgenol. 2006;187:313–21.
Edwards SD, Lipson JA, Ikeda DM, Lee JM. Updates and revisions to the BI-RADS magnetic resonance imaging lexicon. Magn Reson Imaging Clin N Am. 2013;21:483–93.
Facius M, Renz DM, Neubauer H, Bottcher J, Gajda M, Camara O, et al. Characteristics of ductal carcinoma in situ in magnetic resonance imaging. Clin Imaging. 2007;31:394–400.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Joe, A., Patterson, S. (2015). Imaging DCIS: Digital/Film-Screening Mammography, Tomosynthesis, MRI, Ultrasonography. In: Newman, L., Bensenhaver, J. (eds) Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2035-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-2035-8_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-2034-1
Online ISBN: 978-1-4939-2035-8
eBook Packages: MedicineMedicine (R0)